Last reviewed · How we verify
Treatment with Dexmedetomidine
Treatment with Dexmedetomidine is a Small molecule drug developed by University Hospital, Limoges. It is currently FDA-approved.
At a glance
| Generic name | Treatment with Dexmedetomidine |
|---|---|
| Sponsor | University Hospital, Limoges |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Continuous Epidural With Dexmedetomidine Adjuvant in Gynecologic Laparotomy (PHASE4)
- Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome (PHASE4)
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Cardiac Index and General Anesthesia Without Opioid. (PHASE2, PHASE3)
- Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control (NA)
- Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Treatment with Dexmedetomidine CI brief — competitive landscape report
- Treatment with Dexmedetomidine updates RSS · CI watch RSS
- University Hospital, Limoges portfolio CI
Frequently asked questions about Treatment with Dexmedetomidine
What is Treatment with Dexmedetomidine?
Treatment with Dexmedetomidine is a Small molecule drug developed by University Hospital, Limoges.
Who makes Treatment with Dexmedetomidine?
Treatment with Dexmedetomidine is developed and marketed by University Hospital, Limoges (see full University Hospital, Limoges pipeline at /company/university-hospital-limoges).
What development phase is Treatment with Dexmedetomidine in?
Treatment with Dexmedetomidine is FDA-approved (marketed).